Symyoo

Symyoo is a Clinical Research Organization (CRO) based in South Korea, operating since 2009 and serving clients in the clinical development of pharmaceutical and biomedical therapies. The company describes itself as a full-service CRO with over 15 years of experience, having conducted more than 250 clinical studies across more than 30 therapeutic areas, including oncology, rare diseases, neurology, and infectious diseases. A notable portion of its clinical trials — approximately two-thirds — have been registrational studies.

Symyoo serves sponsors and research partners seeking end-to-end clinical development support, from early-phase first-in-human studies through to late-phase confirmatory trials and post-market surveillance. The organization employs experienced professionals with expertise across clinical research disciplines and positions itself as a partner for healthcare innovation.

Clinical Development Services

• Clinical Development Services: Full-service support across the clinical trial lifecycle.
• Project Management: Coordination and oversight of clinical trial operations.
• Biostatistics: Statistical analysis and study design support.
• Clinical Monitoring: On-site and remote monitoring of trial conduct.
• Data Management: Collection, validation, and management of clinical trial data.
• Pharmacovigilance & Medical Safety: Safety monitoring and adverse event reporting.
• Medical Affairs & Writing: Medical writing and affairs support for regulatory and scientific documentation.
• Global Consulting: Strategic consulting for international clinical development programs.
• Regulatory Service: Regulatory strategy and submission support.
• QA & Training: Quality assurance oversight and staff training programs.

Capabilities by Phase

• Early Phase: First-in-human studies focused on testing a new compound's safety and clinical relevance.
• Late Phase: Confirmatory studies evaluating efficacy and monitoring adverse reactions.
• Post-Market Surveillance and Observational Studies: Studies conducted after product approval, including observational and other study types.

Products — Smart Trial Solutions

• Smart Trial Solutions: A suite of trial management tools designed to accelerate clinical trial operations and ensure data consistency and accuracy.
• SYNeRA™ EDC: An electronic data capture system offered as part of the Smart Trial Solutions platform.
• SYNeRA™ CTMS: A clinical trial management system offered alongside the EDC product to support trial operations.

Notable Developments and Partnerships

• In May 2025, Symyoo signed a Memorandum of Understanding (MoU) with the Research Institute of Pharmaceutical Sciences (RIPS) at Sookmyung Women's University to strengthen research exchange and collaboration in basic and translational biomedical sciences.
• Symyoo participated in Bio Korea 2025, where it highlighted its clinical research capabilities and experience across therapeutic areas.
• The company has accumulated more than 43,500 units of a referenced operational metric across its history from 2009 to 2026, reflecting the scale of its clinical research activity.

Symyoo also actively recruits professionals to join its team, emphasizing opportunities for individuals to contribute to the development of future medicines through its clinical research operations.